Nektar Therapeutics (NKTR) Change in Receivables: 2010-2024
Historic Change in Receivables for Nektar Therapeutics (NKTR) over the last 15 years, with Dec 2024 value amounting to $2.2 million.
- Nektar Therapeutics' Change in Receivables rose 320.62% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.0 million, marking a year-over-year increase of 163.76%. This contributed to the annual value of $3.0 million for FY2024, which is 163.76% up from last year.
- Nektar Therapeutics' Change in Receivables amounted to $2.2 million in Q4 2024, which was up 159.29% from $850,000 recorded in Q3 2024.
- In the past 5 years, Nektar Therapeutics' Change in Receivables ranged from a high of $7.7 million in Q1 2022 and a low of -$20.2 million during Q2 2022.
- In the last 3 years, Nektar Therapeutics' Change in Receivables had a median value of -$74,500 in 2023 and averaged -$1.5 million.
- Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 1,739.18% in 2020, then crashed by 6,992.63% in 2022.
- Quarterly analysis of 5 years shows Nektar Therapeutics' Change in Receivables stood at -$8.0 million in 2020, then surged by 68.87% to -$2.5 million in 2021, then crashed by 121.86% to -$5.6 million in 2022, then surged by 82.00% to -$999,000 in 2023, then soared by 320.62% to $2.2 million in 2024.
- Its Change in Receivables was $2.2 million in Q4 2024, compared to $850,000 in Q3 2024 and -$2.4 million in Q2 2024.